XEMBIFY 200 mg/mL

XEMBIFY 200 mg/mL is a subcutaneous immune globulin solution used to treat immune deficiencies. This pharmaceutical product supports the immune system and is administered via subcutaneous injection.

XEMBIFY 200 mg/mL is primarily used to manage primary immune deficiencies, providing essential antibodies to support the immune system. This immune globulin subcutaneous solution helps individuals who have difficulty producing sufficient antibodies on their own. It is often prescribed for conditions where the body's immune response is compromised, requiring supplemental antibody therapy.

Common effects of XEMBIFY 200 mg/mL may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some individuals might experience mild systemic reactions like headache or fatigue. These effects are generally temporary and should be monitored.

XEMBIFY 200 mg/mL should be handled with care, ensuring proper storage and administration techniques. It is important to follow healthcare provider instructions for subcutaneous injection. Individuals with known allergies to immune globulin products should consult their healthcare provider before use.

XEMBIFY 200 mg/mL may interact with certain medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.